(Q30663685)

English

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference (English)

1 reference

Europe PubMed Central

26 June 2017

atrial fibrillation

0 references

Carina Blomström-Lundqvist

10

object named as

Carina Blomstrom-Lundqvist

1 reference

Europe PubMed Central

26 June 2017

Michele Gulizia

object named as

Michele Gulizia

26

0 references

object named as

Jens Cosedis Nielsen

47

0 references

Paulus Kirchhof

object named as

Paulus Kirchhof

1

0 references

71

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

26 June 2017

63

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

26 June 2017

Karl-Heinz Kuck

37

object named as

Karl-Heinz Kuck

1 reference

Europe PubMed Central

26 June 2017

Angelo Auricchio

6

object named as

Angelo Auricchio

1 reference

Europe PubMed Central

26 June 2017

16

object named as

Hugh Calkins

1 reference

Europe PubMed Central

26 June 2017

50

object named as

Burkert Pieske

1 reference

Europe PubMed Central

26 June 2017

Jeroen Joost Bax

8

object named as

Jeroen Bax

1 reference

Europe PubMed Central

26 June 2017

Günter Breithardt

2

object named as

Günter Breithardt

1 reference

Europe PubMed Central

26 June 2017

Isabelle C Van Gelder

66

object named as

Isabelle C Van Gelder

1 reference

Europe PubMed Central

26 June 2017

Łukasz Szumowski

62

object named as

Lukasz Szumowski

1 reference

Europe PubMed Central

26 June 2017

Tatjana S Potpara

52

object named as

Tatjana Potpara

1 reference

Europe PubMed Central

26 June 2017

38

object named as

Deirdre Lane

1 reference

Europe PubMed Central

26 June 2017

Giuseppe Boriani

12

object named as

Giuseppe Boriani

1 reference

Europe PubMed Central

26 June 2017

Stavros Apostolakis

5

object named as

Stavros Apostolakis

1 reference

Europe PubMed Central

26 June 2017

Ulrich Schotten

58

object named as

Ulrich Schotten

1 reference

Europe PubMed Central

26 June 2017

Michael D. Ezekowitz

22

object named as

Michael Ezekowitz

1 reference

Europe PubMed Central

26 June 2017

Harry J. G. M. Crijns

19

object named as

Harry Crijns

1 reference

Europe PubMed Central

26 June 2017

Dobromir Dobrev

21

object named as

Dobromir Dobrev

1 reference

Europe PubMed Central

26 June 2017

72

object named as

A John Camm

1 reference

Europe PubMed Central

26 June 2017

Thorsten Lewalter

40

object named as

Thorsten Lewalter

1 reference

Europe PubMed Central

26 June 2017

Gerlinde Benninger

9

object named as

Gerlinde Benninger

1 reference

Europe PubMed Central

26 June 2017

13

object named as

Axel Brandes

1 reference

Europe PubMed Central

26 June 2017

23

object named as

Thomas Fetsch

1 reference

Europe PubMed Central

26 June 2017

27

object named as

Guido Hack

1 reference

Europe PubMed Central

26 June 2017

Laurent Haegeli

28

object named as

Laurent Haegeli

1 reference

Europe PubMed Central

26 June 2017

Stéphane Hatem

29

object named as

Stephane Hatem

1 reference

Europe PubMed Central

26 June 2017

Hein Heidbuchel

31

object named as

Hein Heidbüchel

1 reference

Europe PubMed Central

26 June 2017

Lukas Kappenberger

34

object named as

Lukas Kappenberger

1 reference

Europe PubMed Central

26 June 2017

39

object named as

Angelika Leute

1 reference

Europe PubMed Central

26 June 2017

41

object named as

Ralf Meyer

1 reference

Europe PubMed Central

26 June 2017

48

object named as

Michael Oeff

1 reference

Europe PubMed Central

26 June 2017

49

object named as

Ali Oto

1 reference

Europe PubMed Central

26 June 2017

51

object named as

Ron Pisters

1 reference

Europe PubMed Central

26 June 2017

Isabelle Richard-Lordereau

56

object named as

Isabelle Richard-Lordereau

1 reference

Europe PubMed Central

26 June 2017

Gerhard Steinbeck

61

object named as

Gerhard Steinbeck

1 reference

Europe PubMed Central

26 June 2017

Sakis Themistoclakis

64

object named as

Sakis Themistoclakis

1 reference

Europe PubMed Central

26 June 2017

Alphons Vincent

68

object named as

Alphons Vincent

1 reference

Europe PubMed Central

26 June 2017

69

object named as

David Werring

1 reference

Europe PubMed Central

26 June 2017

James A Reiffel

55

object named as

James Reiffel

1 reference

Europe PubMed Central

26 June 2017

Andreas Clemens

18

object named as

Andreas Clemens

1 reference

Europe PubMed Central

26 June 2017

60

object named as

Kenneth Stein

1 reference

Europe PubMed Central

26 June 2017

author name string

Etienne Aliot

3

1 reference

Europe PubMed Central

26 June 2017

Sana Al Khatib

4

1 reference

Europe PubMed Central

26 June 2017

Christophe Bailleul

7

1 reference

Europe PubMed Central

26 June 2017

Lucas Boersma

11

1 reference

Europe PubMed Central

26 June 2017

Helen Brown

14

1 reference

Europe PubMed Central

26 June 2017

Martina Brueckmann

15

1 reference

Europe PubMed Central

26 June 2017

Barbara Casadei

17

1 reference

Europe PubMed Central

26 June 2017

Roland Derwand

20

1 reference

Europe PubMed Central

26 June 2017

Andrea Gerth

24

1 reference

Europe PubMed Central

26 June 2017

Anne Gillis

25

1 reference

Europe PubMed Central

26 June 2017

Karl Georg Häusler

30

1 reference

Europe PubMed Central

26 June 2017

Jessica Hernandez-Brichis

32

1 reference

Europe PubMed Central

26 June 2017

Pierre Jais

33

1 reference

Europe PubMed Central

26 June 2017

Joseph Kautzner

35

1 reference

Europe PubMed Central

26 June 2017

Steven Kim

36

1 reference

Europe PubMed Central

26 June 2017

Lluis Mont

42

1 reference

Europe PubMed Central

26 June 2017

Gregory Moses

43

1 reference

Europe PubMed Central

26 June 2017

Markus Mueller

44

1 reference

Europe PubMed Central

26 June 2017

Felix Münzel

45

1 reference

Europe PubMed Central

26 June 2017

Michael Näbauer

46

1 reference

Europe PubMed Central

26 June 2017

Lars Rasmussen

53

1 reference

Europe PubMed Central

26 June 2017

Ursula Ravens

54

1 reference

Europe PubMed Central

26 June 2017

Herbert Schäfer

57

1 reference

Europe PubMed Central

26 June 2017

Wim Stegink

59

1 reference

Europe PubMed Central

26 June 2017

Karen Thomitzek

65

1 reference

Europe PubMed Central

26 June 2017

Berndt von Stritzky

67

1 reference

Europe PubMed Central

26 June 2017

Stephan Willems

70

1 reference

Europe PubMed Central

26 June 2017

publication date

27 August 2013

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

15

1 reference

Europe PubMed Central

26 June 2017

11

1 reference

Europe PubMed Central

26 June 2017

1540-1556

1 reference

Europe PubMed Central

26 June 2017

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Dronedarone in High-Risk Permanent Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Regulatory pathways for development of antiarrhythmic drugs for management of atrial fibrillation/flutter

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Variants conferring risk of atrial fibrillation on chromosome 4q25.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Frailty and its quantitative clinical evaluation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

P wave signal-averaged electrocardiography to identify risk for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

P-wave signal averaging identifies patients prone to alcohol-induced paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Amiodarone versus sotalol for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Noninvasive mapping of human atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Silent brain infarcts: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Left atrial catheter ablation and ischemic stroke

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: results of the MACPAF study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Silent brain infarcts and the risk of dementia and cognitive decline.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial fibrillation and the risk of incident dementia: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial fibrillation and the risk of cerebral white matter lesions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Microembolism and catheter ablation II: effects of cerebral microemboli injection in a canine model

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Cerebral microbleeds: a guide to detection and interpretation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Left Ventricular Mass and Risk of Stroke in an Elderly Cohort

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Impact of heart failure with normal ejection fraction on the occurrence of ischaemic stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

MRI of left ventricular function

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Echocardiographic assessment of myocardial strain

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Left atrial size and the risk of stroke and death. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Assessment of echocardiographic left atrialenlargement in patients with atrial fibrillation. An electrovectorcardiographic study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Clinical utility of multimodality LA imaging: assessment of size, function, and structure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Effects of atrial fibrillation substrate and spatiotemporal organization on atrial defibrillation thresholds

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Influence of blood pressure on left atrial size. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Right atrial scar detection after catheter ablation: Comparison of 2D and high spatial resolution 3D-late enhancement magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

D-dimer level influences thromboembolic events in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulati

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Exploiting common genetic variation to make anticoagulation safer

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Meta-analysis identifies six new susceptibility loci for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Whole genome expression differences in human left and right atria ascertained by RNA sequencing

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design:

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiolog

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Gone Fishing (for Silent Atrial Fibrillation)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Atrial and Ventricular Volume and Function Evaluated by Magnetic Resonance Imaging in Patients With Persistent Atrial Fibrillation Before and After Cardioversion

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Fibrin D-Dimer, Tissue-Type Plasminogen Activator, von Willebrand Factor, and Risk of Incident Stroke in Older Men

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT232

21 January 2018

Preoperative statin therapy for patients undergoing cardiac surgery

1 reference

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD008493.PUB2

12 January 2024

Identifiers

10.1093/EUROPACE/EUT232

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30663685&oldid=2051848073"